Genenta Science S.p.A. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GNTA Nasdaq 2834 www.genenta.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Genenta Science S.p.A.

Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs - Mar 27th, 2026 3:00 am
Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini - Mar 24th, 2026 1:27 am
European Equities Traded in the US as American Depositary Receipts Higher Tuesday - Mar 17th, 2026 9:18 am
Genenta, Evolving into Saentra Forge, Announces CEO’s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University - Mar 13th, 2026 3:00 am
Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business - Feb 27th, 2026 5:53 pm
Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform - Feb 27th, 2026 2:00 am
Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator - Jan 27th, 2026 1:00 am
European Equities Traded in the US as American Depositary Receipts Gain Friday - Jan 2nd, 2026 9:09 am
Genenta Science Provides Update on CEO Ownership - Dec 19th, 2025 12:30 am
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial - Nov 24th, 2025 2:00 am
US-China Trade Optimism Lifts US Equity Futures Pre-Bell - Oct 27th, 2025 7:00 am
Genenta Science (GNTA): Assessing Valuation After Expanded Anemocyte Partnership Spurs Industry Optimism - Oct 27th, 2025 3:07 am
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares - Oct 26th, 2025 6:30 pm
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production - Oct 24th, 2025 2:00 am
Genenta Science And 2 Other Penny Stocks To Consider - Oct 14th, 2025 12:05 pm
Genenta Science Leads The Charge With 2 Other Promising Penny Stocks - Jul 8th, 2025 12:05 pm
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals - Jul 1st, 2025 3:00 am
Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference - May 8th, 2025 5:00 am
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies - May 7th, 2025 5:00 am